Back to Exposants
MERCK
Merck, a leading science and technology company, operates across life science, healthcare, and electronics. More than 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2024, Merck generated sales of € 21.2 billion in 65 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances.
This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds global rights to the Merck name and brand.
The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.
Merck has proudly been active in Tunisia for more than 50 years, demonstrating our long-term commitment to the region through two entities: the first, established in 2008, serves as the regional headquarters for North and French-speaking Africa and the second, founded in 2009, focuses on promoting pharmaceutical products and providing medical and scientific information. This strategic presence strengthens our ability to effectively manage and oversee our operations in these areas.
This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds global rights to the Merck name and brand.
The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.
Merck has proudly been active in Tunisia for more than 50 years, demonstrating our long-term commitment to the region through two entities: the first, established in 2008, serves as the regional headquarters for North and French-speaking Africa and the second, founded in 2009, focuses on promoting pharmaceutical products and providing medical and scientific information. This strategic presence strengthens our ability to effectively manage and oversee our operations in these areas.